epidem
sever
acut
respiratori
syndrom
sar
swept
countri
affect
report
peopl
left
patient
dead
almost
paralys
asian
economi
aggress
quarantin
measur
possibl
aid
rise
summer
temperatur
success
termin
first
erupt
sar
provid
least
tempor
break
allow
us
consolid
learn
far
plan
futur
review
genom
sar
coronaviru
sarscov
phylogeni
antigen
structur
immun
respons
potenti
therapeut
intervent
sar
epidem
flare
new
infecti
diseas
known
sever
acut
respiratori
syndrom
sar
appear
guangdong
provinc
southern
china
mainli
character
flulik
symptom
includ
high
fever
exceed
myalgia
dri
nonproduct
dyspnea
lymphopaenia
infiltr
chest
radiographi
case
result
pneumonia
led
acut
breath
problem
requir
artifici
respir
overal
mortal
rate
vari
profoundli
age
although
sar
affect
rel
children
gener
appear
milder
paediatr
age
group
mortal
rate
elderli
high
although
accur
inform
precis
origin
diseas
avail
chines
ministri
health
report
outbreak
unexplain
pneumonia
world
health
organ
februari
period
novemb
februari
case
five
death
due
atyp
pneumonia
origin
thought
caus
chlamydia
pneumonia
occur
southern
chines
provinc
guangdong
chines
doctor
treat
patient
guangdong
spread
infect
outsid
mainland
china
travel
hong
kong
februari
resid
ninth
floor
hotel
metropol
patient
develop
symptom
transfer
hospit
februari
die
follow
day
subsequ
ten
secondaryinfect
guest
hotel
eight
ninth
floor
two
eleventh
fourteenth
floor
board
plane
carri
infect
singapor
vietnam
canada
unit
state
make
sar
first
epidem
transmit
air
travel
epidem
final
wane
day
count
cumul
number
probabl
sar
case
death
worldwid
geograph
area
span
countri
carlo
urbani
infecti
diseas
expert
call
hanoi
first
realiz
chines
doctor
hong
kong
suffer
previous
unknown
diseas
alert
author
follow
unpreced
collabor
laboratori
scientist
worldwid
previous
unidentifi
coronaviru
isol
vero
cell
inocul
clinic
nasopharyng
oropharyng
sputum
specimen
patient
associ
viru
diseas
confirm
macaqu
inocul
viru
develop
symptom
similar
observ
human
case
sar
like
scientist
chines
academi
militari
medic
scienc
observ
seem
coronaviru
particl
electron
micrograph
februari
howev
r
e
v
e
w
indic
outbreak
first
introduct
sarscov
human
popul
present
accident
infect
research
handl
pathogen
seem
pose
greatest
risk
renew
spread
viru
recent
case
singapor
shown
transmiss
emerg
infecti
diseas
stop
inform
sarscov
reemerg
human
popul
coronavirus
name
corona
solislik
appear
electron
microscop
caus
clubshap
peplom
radiat
outward
viral
envelop
fig
spheric
capsid
contain
positivestrand
rna
genom
kb
largest
kind
coronavirus
subdivid
three
group
basi
serolog
genet
properti
broad
host
rang
extend
man
turkey
typic
associ
respiratori
enter
hepat
central
nervou
system
diseas
man
caus
mainli
upperrespiratorytract
infect
respons
larg
proport
common
cold
sequenc
analysi
reveal
organ
base
fra
isol
genbank
accno
see
sar
coronaviru
fra
onlin
link
genom
sarscov
fig
show
characterist
featur
coronavirus
fig
nucleotid
contain
predict
rna
leader
sequenc
preced
untransl
region
utr
span
nucleotid
two
overlap
open
read
frame
encompass
approxim
twothird
genom
nucleotid
downstream
utr
translat
readthrough
ribosom
frameshift
mechan
allow
translat
overlap
read
frame
singl
polyprotein
virusencod
proteinas
name
sampl
avail
analysi
feel
confid
enough
challeng
author
publish
find
close
contact
sick
patient
facilit
persontoperson
transmiss
viru
appar
sarscov
spread
droplet
effici
infect
seem
low
infect
index
ref
case
howev
singl
person
infect
high
number
peopl
yet
satisfactori
explan
socal
superspread
phenomenon
viru
close
homolog
sarscov
isol
palm
civet
racoon
dog
consid
delicaci
southern
china
indic
viru
could
jump
recent
mammal
man
howev
second
search
anoth
group
fail
reveal
trace
sarscov
anim
speci
includ
palm
civet
although
unlik
possibl
human
infect
sarsposit
anim
formal
exclud
meantim
differ
sarscov
isol
sequenc
hope
allow
us
trace
chain
transmiss
back
origin
sar
epidem
caus
global
panic
huge
econom
damag
asian
economi
contain
primarili
aggress
quarantin
measur
addit
benefici
factor
could
includ
attenu
viru
follow
prolong
passag
human
popul
onset
summer
higher
temperatur
gener
decreas
incid
least
respiratori
infect
natur
reservoir
viru
could
serv
launch
pad
anoth
sar
outbreak
next
winterspr
season
lucki
howev
abil
viru
cross
speci
barrier
could
result
rare
seri
event
unlik
repeat
retrospect
serolog
studi
detect
antisarscov
antibodi
normal
popul
assumpt
function
remain
protein
made
analog
coronavirus
although
knowledg
biolog
function
protein
also
incomplet
see
tabl
inform
encod
protein
togeth
host
factor
protein
might
form
viral
replicationtranscript
machineri
associ
membran
structur
infect
cell
peculiar
featur
replic
cycl
coronavirus
describ
box
remain
part
genom
encod
four
structur
protein
arrang
order
papainlik
cystein
proteas
plpro
cystein
proteas
cleav
polyprotein
individu
polypeptid
provid
protein
requir
replic
transcript
whearea
group
coronavirus
contain
two
paralog
plpro
one
found
sarscov
genom
encod
helicas
atpas
dna
possibl
also
rna
duplexunwind
activ
least
express
escherichia
coli
comput
analysi
predict
carboxyterminu
encod
mrna
methyltransferas
final
end
genom
second
utr
follow
poli
tract
found
utr
contain
stemloop
iilik
motif
motif
also
report
astrovirus
one
equin
rhinoviru
avian
infecti
bronchiti
viru
ibv
typic
featur
coronavirus
presenc
transcriptionregulatori
sequenc
tr
import
rna
transcript
regul
fig
short
motif
usual
found
end
leader
rna
except
preced
translat
orf
thiel
colleagu
isol
one
genom
eight
subgenom
rna
fra
strain
sequenc
end
identifi
conserv
sequenc
locat
coronavirus
spike
protein
e
envelop
protein
membran
glycoprotein
n
nucleocapsid
protein
furthermor
structur
protein
region
sarscov
genom
contain
sever
gene
encod
addit
nonstructur
protein
known
accessori
gene
fig
molecul
seem
dispens
viru
viabil
vitro
vivo
delet
creat
virus
attenu
accessori
gene
differ
significantli
among
three
coronaviru
group
also
refer
groupspecif
gene
sarscov
eight
predict
orf
unknown
function
region
genom
lack
haemagglutinin
esteras
gene
encod
almost
group
virus
analys
base
sequenc
sarscov
fra
isol
genbank
access
number
transmembran
domain
tmd
predict
use
program
psort
threshold
less
glycosyl
site
predict
use
netnglyc
server
see
netnglyc
onlin
link
inform
function
predict
taken
ref
nsp
nonstructur
protein
coronavirus
contain
largest
rna
genom
describ
far
positivesens
singlestrand
rna
molecul
cap
poli
tail
life
cycl
coronaviru
start
spike
protein
form
distinct
eponym
crown
observ
coronavirus
interact
receptor
domain
entri
probabl
mediat
domain
occur
membran
fusion
rna
genom
releas
cytoplasm
replic
take
place
host
translat
machineri
translat
overlap
open
read
frame
ribosom
frameshift
mechan
produc
singl
polyprotein
cleavag
viral
encod
proteinas
yield
compon
necessari
assembl
viral
replic
complex
synthes
fulllength
negativestrand
rna
addit
discontinu
transcript
strategi
negativestrand
synthesi
produc
nest
set
subgenom
negativesens
rna
process
transcript
regulatori
sequenc
tr
present
end
leader
sequenc
except
upstream
translat
gene
import
postul
fuse
end
nascent
subgenom
minu
strand
antisens
leader
sequenc
discontinu
synthes
minu
strand
act
templat
synthesi
positivesens
mrna
altern
hypothesi
propos
mrna
molecul
gener
discontinu
transcript
positivestrand
synthesi
figur
show
positivesens
mrna
product
almost
case
orf
translat
nucleocapsid
n
protein
genom
rna
assembl
cytoplasm
form
helic
nucleocapsid
core
structur
acquir
envelop
bud
intracellular
membran
endoplasm
reticulum
er
golgi
apparatu
membran
envelop
e
protein
accommod
lipid
bilay
transport
er
bud
compart
nucleocapsid
probabl
interact
protein
trigger
assembl
transport
viru
golgi
apparatu
sugar
moieti
modifi
coronavirus
protein
cleav
domain
protein
incorpor
virion
transport
cell
surfac
final
viru
releas
host
cell
fusion
virioncontain
vesicl
plasma
membran
common
leader
sequenc
end
mrna
shown
red
observ
rais
intrigu
hypothesi
delet
observ
human
isol
could
increas
fit
viru
human
host
allow
spread
human
popul
lack
proofread
mechan
rna
virus
gener
character
high
mutabl
high
mutat
rate
result
continu
evolv
viral
speci
allow
viru
escap
host
defenc
addit
coronavirus
high
frequenc
rna
recombin
theoret
potenti
acceler
emerg
new
viral
speci
owe
limit
number
sequenc
isol
howev
earli
draw
reliabl
conclus
concern
mutat
rate
sarscov
interest
aminoacid
chang
report
far
two
recurr
nonconserv
aminoacid
substitut
gli
asp
ile
thr
antigen
domain
spike
protein
gli
ile
found
hong
kong
front
nine
predict
orf
fit
descript
tr
fig
contrast
marra
et
al
rota
et
al
propos
differ
trss
respect
sequenc
preced
predict
gene
experiment
evid
function
provid
although
overal
organ
sarscov
genom
similar
coronavirus
fig
aminoacid
conserv
encod
protein
usual
low
fig
tabl
help
groundwork
laid
previou
gener
coronaviru
research
sar
epidem
first
infecti
diseas
outbreak
fulli
benefit
revolutionari
technolog
postgenom
era
less
month
initi
identif
viru
infecti
agent
sar
two
independ
genom
sequenc
viru
obtain
within
month
genom
sequenc
independ
clinic
isol
made
avail
genbank
databas
see
box
detail
compar
analysi
isol
reveal
sequenc
conserv
differ
howev
allow
straightforward
organ
viral
isol
two
famili
origin
mainland
china
hong
kong
origin
index
case
hong
kong
hotel
fig
perhap
interest
observ
made
import
question
follow
identif
sarscov
whether
repres
complet
new
group
variant
one
three
known
group
combin
group
phylogenet
analysi
base
first
avail
nucleotid
highli
conserv
polymeras
gene
indic
sarscov
distinct
three
known
group
marra
rota
also
reach
conclus
propos
sarscov
place
group
fig
fig
indic
close
relat
member
group
might
share
common
ancestor
moreov
conclus
corrobor
strike
observ
cystein
residu
domain
sarscov
spike
protein
spatial
conserv
compar
group
consensu
sequenc
wherea
cystein
conserv
compar
group
consensu
sequenc
fig
analysi
support
conclus
sarscov
viru
split
earli
group
virus
evolv
independ
long
period
time
although
littl
known
sarscov
protein
homolog
known
coronaviru
protein
use
predict
featur
sever
sarscov
protein
could
interest
target
antivir
drug
vaccin
viral
enzym
essenti
viru
replic
attract
candid
develop
small
antivir
molecul
wherea
structur
protein
repres
obviou
target
vaccin
develop
basi
xray
crystal
structur
transmiss
gastroenter
coronaviru
tgv
human
coronaviru
threedimension
model
correspond
sar
viru
protein
propos
model
use
reduc
number
compound
test
find
effect
proteas
inhibitor
inde
activ
form
proteas
alreadi
express
ecoli
immedi
use
drug
screen
helicas
alreadi
avail
recombin
form
repres
anoth
attract
target
highthroughput
screen
plpro
anoth
potenti
candid
antivir
drug
although
homolog
index
case
group
wherea
asp
thr
found
mainland
isol
anoth
nonconserv
substitut
gli
arg
domain
found
strain
tempt
specul
mutat
repres
adapt
new
host
immun
respons
addit
inform
ongo
variabl
studi
obtain
directli
sar
coronaviru
resourc
see
onlin
link
genbank
databas
avail
scientif
commun
sequenc
isol
come
china
strain
singapor
strain
taiwan
strain
vietnam
strain
germani
strain
itali
strain
canada
strain
deriv
patient
repres
primari
secondari
contact
place
isol
access
number
cov
spike
protein
group
coronavirus
use
apn
receptor
wherea
group
mous
hepat
viru
mhv
use
glycoprotein
belong
carcinoembryon
antigen
famili
receptor
target
cell
whether
hapn
bind
domain
receptor
vivo
remain
shown
protrud
domain
adjac
domain
consist
stem
transmembran
region
short
cytoplasm
tail
analog
coronaviru
protein
sarscov
spike
protein
contain
two
heptad
repeat
locat
domain
propos
repeat
might
trigger
fusion
viral
envelop
cell
membran
shown
recent
mhv
group
group
virus
spike
cleav
matur
two
subunit
stay
noncoval
attach
exact
role
cleavag
process
unclear
seem
influenc
infect
howev
may
enhanc
fusion
activ
matur
sarscov
seem
contain
uncleav
spike
protein
cleavag
bind
target
cell
exclud
conclud
spike
protein
target
develop
agent
block
viru
bind
cellular
receptor
dock
site
peptid
might
inhibit
fusion
sever
addit
target
studi
identifi
first
e
protein
comput
analysi
predict
long
transmembran
domain
close
nterminu
two
ntermin
glycosyl
site
low
level
aminoacid
similar
coronavirus
second
glycoprotein
polypeptid
consist
short
ntermin
ectodomain
nglycosyl
site
three
transmembran
segment
cterminu
locat
interior
side
viral
envelop
close
resembl
glycoprotein
group
virus
third
n
protein
phosphoprotein
interact
viral
genom
rna
form
helic
nucleocapsid
low
level
conserv
coronavirus
notabl
except
report
interfer
replic
sar
viru
vitro
licens
drug
vaccin
avail
largescal
screen
exist
antivir
big
chemic
librari
potenti
replic
inhibitor
success
present
promis
substanc
glycyrrhizin
compon
liquoric
root
also
activ
hiv
compound
identifi
smallscal
experi
involv
small
number
known
antivir
compound
develop
assay
base
viral
enzym
activ
amen
highthroughput
screen
exist
new
chemic
librari
like
identifi
effect
compound
near
futur
nevertheless
unless
put
compound
alreadi
licens
exist
product
advanc
stage
develop
avail
treat
patient
structur
avail
given
fundament
role
viru
biolog
rnadepend
rna
polymeras
rdrp
high
list
promis
target
differ
possibl
vaccin
target
glycoprotein
attract
candid
exploit
protein
form
larg
surfac
project
characterist
coronavirus
fig
like
compos
homotrim
heavili
glycosyl
aminoacid
protein
contain
aminotermin
bulbou
head
compris
receptorbind
domain
also
believ
respons
host
tissu
tropism
viru
nonrepl
virus
viral
vector
base
adenoviru
canarypox
modifi
vaccinia
viru
ankara
mva
alphaviru
particular
devlop
nonrepl
coronaviruslik
particl
mimic
structur
nativ
virion
could
prove
promis
search
success
vaccin
display
larg
repertoir
antigen
site
discontinu
epitop
howev
approach
includ
passiv
immunotherapi
need
care
evalu
vaccin
develop
felin
coronaviru
actual
exacerb
diseas
vaccin
anim
challeng
wildtyp
viru
killedviru
vaccin
readi
test
phase
clinic
trial
like
avail
soon
normal
circumst
vaccin
take
year
clinic
develop
enter
phase
clinic
trial
timelin
could
shorten
consider
diseas
burden
state
medic
emerg
induc
regulatori
agenc
fast
track
approv
process
conclus
develop
therapeut
strategi
new
coronaviru
seem
possibl
avail
technolog
unreach
goal
level
hiv
hepat
c
viru
given
enough
time
econom
pressur
antivir
drug
human
monoclon
antibodi
vaccin
sirna
activ
sarscov
like
becom
avail
remain
question
whether
time
develop
effect
therapi
anoth
epidem
emerg
human
popul
sar
return
winter
still
need
reli
primarili
quarantin
measur
contain
diseas
equal
import
develop
technolog
allow
rapid
simpl
diagnosi
sar
worri
howev
scenario
viru
reemerg
coupl
year
caus
econom
incent
compani
invest
sar
disappear
none
measur
develop
implement
near
futur
cellular
protein
essenti
viru
replic
also
overlook
possibl
target
new
technolog
doublestrand
small
interf
rna
sirna
consider
futur
potenti
yet
still
riddl
practic
difficulti
present
research
work
develop
efficaci
deliveri
system
sirna
follow
success
conclus
research
still
need
prove
potenti
anim
model
infect
antibodi
abl
neutral
viral
infect
also
like
effect
way
prevent
cure
diseas
passiv
immunotherapi
use
sera
convalesc
patient
initi
propos
treatment
diseas
given
excel
track
record
human
monoclon
antibodi
treatment
cancer
infecti
diseas
prove
fruit
area
therapeut
develop
inde
monoclon
antibodi
obtain
immort
b
lymphocyt
sar
convalesc
patient
shown
neutral
viru
infect
vitro
prevent
viru
replic
mous
model
sarscov
infect
lanzavecchia
rr
unpublish
observ
cours
safe
effect
vaccin
would
ideal
solut
would
prevent
diseas
vaccin
peopl
vaccin
would
also
curtail
spread
viru
although
short
period
time
pass
sinc
sarscov
identifi
infecti
agent
respons
epidem
candid
vaccin
base
kill
viru
alreadi
avail
efficaci
still
need
shown
laboratori
possibl
other
process
test
vaccin
basi
inactiv
sar
viru
preclin
model
addit
tradit
approach
number
newer
technolog
use
includ
subunit
vaccin
contain
recombin
spike
protein
express
mammalian
cell
yeast
either
alon
combin
sarscov
antigen
altern
antigen
could
deliv
dna
immun
figur
domain
sarscov
spike
structur
relat
group
coronavirus
schemat
represent
cystein
posit
domain
group
coronavirus
compar
sarscov
spike
protein
horizont
bar
repres
aminoacid
sequenc
case
sarscov
ibv
consensu
profil
gener
group
con
group
con
bar
drawn
scale
rel
cystein
posit
indic
rectangular
bar
cystein
conserv
within
consensu
report
colour
line
connect
cystein
conserv
sarscov
domain
consensu
sequenc
gener
group
green
group
red
ibv
sequenc
blue
